The University of Chicago Header Logo

Connection

Ardaman Shergill to Biomarkers, Tumor

This is a "connection" page, showing publications Ardaman Shergill has written about Biomarkers, Tumor.
Connection Strength

1.182
  1. Association of Activating GNAS Mutations and Outcomes with Chemotherapy in Metastatic Appendiceal Adenocarcinoma. Ann Surg Oncol. 2026 Apr; 33(4):3453-3461.
    View in: PubMed
    Score: 0.486
  2. Utility of Circulating Tumor DNA Assessment in Characterizing Recurrence Sites after Optimal Resection for Metastatic Colorectal Cancer. J Am Coll Surg. 2024 06 01; 238(6):1013-1020.
    View in: PubMed
    Score: 0.423
  3. Consensus Molecular Subtypes Inform HIPEC Agent Selection in Colorectal Cancer Peritoneal Metastases. Ann Surg Oncol. 2026 Jul; 33(7):6140-6145.
    View in: PubMed
    Score: 0.121
  4. Investigating the Use of Circulating Tumor DNA in Early-Stage Colon Cancer. Oncology (Williston Park). 2022 10 07; 36(10):620-626.
    View in: PubMed
    Score: 0.096
  5. Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical Trial. JAMA Oncol. 2026 02 01; 12(2):149-158.
    View in: PubMed
    Score: 0.030
  6. Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression. Clin Lung Cancer. 2023 05; 24(3):e117-e121.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.